How Neurosurgeons Diagnose And Treat Skull Base Tumours
Skull base tumours develop in the complex area where the underside of the brain meets the eye sockets, sinuses, ears, major blood vessels and upper spinal cord. Some are benign, such as meningiomas, vestibular schwannomas and pituitary adenomas, while others are cancerous or may behave aggressively. Even a slow-growing tumour can cause serious problems because the skull base contains so many essential nerves and structures in a small space.
Diagnosis and treatment require careful coordination between neurosurgeons, neurologists, radiologists, endocrinologists, ear, nose and throat specialists, ophthalmologists and radiation oncologists. The right plan depends on the tumour’s size, location, biological behaviour and effect on the patient’s health. Australians seeking care may begin with a general practitioner, then receive referral to a metropolitan neurosurgical unit in Sydney, Melbourne, Brisbane, Perth or another major centre.
Understanding Skull Base Tumours
The skull base is divided into anterior, middle and posterior regions. A tumour in the anterior skull base may affect the frontal lobes, nasal passages or optic nerves. Growth in the middle skull base can involve the pituitary gland, cavernous sinus, hearing structures and facial sensation. Posterior skull base tumours may press on the brainstem, cerebellum or lower cranial nerves.
Common examples include meningioma, pituitary tumour, chordoma, craniopharyngioma, vestibular schwannoma and metastasis from cancer elsewhere in the body. Some lesions are discovered during scans for unrelated concerns. Others gradually produce headaches, double vision, hearing loss, facial numbness, balance problems, seizures, hormonal changes or difficulty swallowing.
The symptoms can resemble migraine, sinus disease, ear problems or ordinary age-related changes. A new pattern of headaches, progressive loss of hearing in one ear, persistent visual disturbance or unexplained hormonal symptoms deserves medical assessment. Sudden weakness, collapse, a seizure or a rapid change in vision requires urgent attention through emergency services.
Clinical Assessment And Imaging
A neurosurgical assessment begins with a detailed history and neurological examination. The clinician may test eye movements, visual fields, facial sensation, hearing, balance, swallowing, limb strength and coordination. Pituitary lesions often require questions about menstrual changes, fertility, thirst, urination, weight, energy and sexual function, followed by blood tests for hormone levels.
Magnetic resonance imaging is usually the main imaging test because it provides detailed views of the brain, nerves and soft tissues. Contrast-enhanced MRI can help distinguish a tumour from inflammation, a cyst or normal anatomical structures. Computed tomography may show bone invasion, calcification or changes around the inner ear and skull base. CT angiography or MR angiography may be needed when a lesion lies near the carotid arteries or other major vessels.
For Australian patients, imaging may occur through a public hospital, private radiology provider or a specialist clinic. Medicare arrangements and private health cover can influence out-of-pocket costs and appointment timing, so it is useful to clarify the referral pathway before testing. People from regional Queensland, the Northern Territory or Western Australia may need to travel to a capital city for advanced imaging and multidisciplinary review.
Confirming The Diagnosis
Scans often suggest what type of tumour is present, but imaging cannot always provide a definitive answer. In selected cases, a biopsy is needed to examine cells under a microscope. The sample may be obtained during surgery or through a carefully planned needle procedure. The location matters: a biopsy can be more hazardous when the tumour lies beside the brainstem, optic pathways or major blood vessels.
Pathologists assess the tumour’s appearance, grade and molecular characteristics. These findings can influence the expected growth rate and the usefulness of surgery, radiation therapy or drug treatment. Genetic and molecular testing is increasingly relevant, particularly when a tumour is unusual, recurrent or difficult to classify. Broader context on this developing area is available in genetic testing guidance.
A treatment conference may bring together neurosurgery, neuroradiology, pathology, oncology, endocrinology and rehabilitation specialists. The team considers the patient’s age, general health, symptoms, work and family responsibilities, as well as the risks of intervention. A small, symptom-free tumour may be monitored with regular MRI rather than treated immediately.
Treatment Options And Surgical Planning
Observation is often appropriate for a slow-growing lesion that causes no significant pressure or neurological loss. Follow-up usually includes repeat MRI and clinical review at defined intervals. If the tumour enlarges or symptoms develop, the plan may change. Medication can also be important: pituitary tumours may respond to hormone-directed drugs, while corticosteroids may temporarily reduce swelling around some lesions.
When treatment is necessary, surgery aims to remove as much tumour as safely possible while protecting vision, hearing, hormone function, blood flow and cranial nerves. Some skull base tumours can be approached through the nose using an endoscope, avoiding a large external incision. Others require a craniotomy or a more complex approach designed around the tumour’s relationship with the brain, bone and blood vessels.
Complete removal is not always the safest goal. A planned subtotal resection followed by stereotactic radiosurgery or fractionated radiotherapy may control a tumour while reducing the chance of permanent neurological damage. Modern navigation systems, intraoperative monitoring and high-resolution imaging help surgeons work with greater precision. Patients can learn more about specialist brain and spine services through the Ocala Neurosurgical Center.
Recovery And Long-Term Monitoring
Recovery depends on the tumour type and the route used to reach it. After surgery, patients may need monitoring in an intensive care or high-dependency unit, followed by assessment of vision, balance, swallowing, hormone levels and cranial nerve function. Rehabilitation may involve physiotherapy, occupational therapy, speech pathology, audiology or assistance with return to work.
Some patients experience temporary fatigue, headaches, nasal congestion or changes in smell after an endoscopic procedure. Hormone replacement may be required after pituitary or hypothalamic surgery. Radiation treatment can control residual or recurrent disease, but follow-up remains essential because tumour growth may return months or years later.
| Approach | When It May Be Used | Main Considerations |
|---|---|---|
| Active surveillance | Small, stable, low-risk or symptom-free tumours | Regular MRI and clinical reviews are essential |
| Microsurgical removal | Tumours causing pressure, neurological symptoms or documented growth | Offers tissue diagnosis and possible complete removal, with procedure-specific risks |
| Endoscopic endonasal surgery | Selected pituitary and central skull base lesions | Uses the nasal passages and requires specialised expertise |
| Stereotactic radiosurgery | Small residual, recurrent or surgically difficult tumours | Delivers focused radiation, although control may take time |
| Fractionated radiotherapy | Larger, infiltrative or radiosurgery-ineligible tumours | Treatment is divided into sessions to protect nearby structures |
| Medication or hormone therapy | Certain pituitary and cancer-related tumours | Effectiveness depends on tumour biology and hormone activity |
A diagnosis can be unsettling, particularly when symptoms affect independence, communication or the ability to work. Clear explanations, written treatment plans and access to second opinions can help patients make informed decisions. Australian patients may also need to coordinate travel, accommodation and support for repeated appointments, especially when treatment is delivered far from home.
Early specialist assessment gives the medical team more options and establishes a useful baseline for future comparison. Contact a qualified neurosurgical or neuro-oncology service promptly when persistent neurological symptoms, visual changes, hearing loss or hormone abnormalities require investigation. Timely imaging, expert review and coordinated follow-up can provide a safer path from diagnosis to treatment.